Atherosclerosis of Femoral Artery Clinical Trial
Official title:
IN.PACT™ Quality of Life Post-Reimbursement Study
To prospectively collect and assess the perception of health-related Quality of Life, Pain and Walking Ability.
To provide both the French National Authority for Health and the French Economic Committee for Health Products requested information on patient-reported outcomes for the IN.PACT™ Admiral™ Drug-Coated Balloon. Patients will be followed using routine clinical practice and the collection of two validated instruments: EuroQOL EQ-5D Quality of Life questionnaire and the Walking Impairment Questionnaire (WIQ). ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03271710 -
Study to Evaluate the Lower Extremity Intervention With Integrated Embolic Protection Using the Vanguard IEP System
|
N/A | |
Completed |
NCT01403077 -
480 Biomedical Bioresorbable Scaffold System in the Treatment of de Novo Superficial Femoral Artery (SFA) Lesions
|
N/A | |
Completed |
NCT01327950 -
Efficacy of the EPIC Nitinol Vascular Stent System in Superficial Femoral Artery (SFA) Lesions
|
N/A | |
Completed |
NCT01700075 -
Physical and Chemical Study of Atherosclerosis Mechanisms
|
Phase 4 | |
Recruiting |
NCT03751527 -
ZENFlex-Registry to Evaluate the Outcome of Bare Metal Stent-assisted Angioplasty
|
N/A | |
Recruiting |
NCT06416644 -
The PORTuguese Registry of Supera Supported Femoral-Fopliteal Revascularization (SupPORT Registry)
|
N/A |